Danaher Corporation (DHR)

126.77
NYSE
Prev Close 126.77
Day Low/High 0.00 / 0.00
52 Wk Low/High 94.59 / 134.50
Exchange NYSE
Shares Outstanding 715.69B
Market Cap 90.73B
Div & Yield N.A. (N.A)

Latest News

Jim Cramer Breaks Down Danaher, Honeywell, Schlumberger Earnings

Jim Cramer Breaks Down Danaher, Honeywell, Schlumberger Earnings

Danaher, Honeywell, Schlumberger and an earnings parade moved the markets today. TheStreet's Jim Cramer breaks down what it all means for investors.

Kraft Heinz, PepsiCo, Marvell Technology: 'Mad Money' Lightning Round

Kraft Heinz, PepsiCo, Marvell Technology: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Kraft Heinz, PepsiCo, Marvell Technology, General Mills, Funko, Signet Jewelers, Abiomed and more.

Video: Jim's Daily Rundown for Thursday

Jim and Zev discuss earnings season so far, Honeywell's impressive results, Danaher, our financials, and Nvidia.

Danaher Update, Plus Our Plan on 3 Other Positions

We like the flexibility we have with our war chest of capital and look forward to our hunt for the next Danaher.

WATCH: Jim Cramer Puts a Pin in Pinterest, Canopy, Danaher and Schlumberger

WATCH: Jim Cramer Puts a Pin in Pinterest, Canopy, Danaher and Schlumberger

Where are you putting your PINS in this market? Jim Cramer is breaking down the latest Wall Street action live.

Danaher's Earnings Drop on GE Biopharma Acquisition Costs

Danaher's Earnings Drop on GE Biopharma Acquisition Costs

Danaher reports first-quarter earnings that beat analysts' estimates though revises forward guidance on costs related to acquisition of GE's biopharma business.

Healthcare Misery, Pinterest IPO, Japan Marketplace, URI Earnings: Market Recon

Healthcare Misery, Pinterest IPO, Japan Marketplace, URI Earnings: Market Recon

Negative political pressure is being felt in an overbearing way on the entire healthcare sector.

Pinterest, JPMorgan Chase, Canopy Growth and Facebook - 5 Things You Must Know

Pinterest, JPMorgan Chase, Canopy Growth and Facebook - 5 Things You Must Know

U.S. stock futures fall as investors adopt a cautious ahead of trading Thursday; Schlumberger and Honeywell report earnings; Pinterest's IPO is priced at $19 a share; JPMorgan Chase makes c-suite changes.

Danaher Reports First Quarter 2019 Results

Danaher Reports First Quarter 2019 Results

WASHINGTON, April 18, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced results for the first quarter 2019.

Exiting Our Danaher Position for a Big Gain

We are ringing the register this afternoon and declaring victory on DHR ahead of earnings.

Video: Jim's Daily Rundown for Wednesday

Jim discusses Abbott Laboratories' earnings release, his view of the Apple-Qualcomm settlement as it relates to the 5G cycle, several upcoming earnings reports, Anadarko Petroleum, UnitedHealth and much more!

What We Are Watching With This Week's Earnings

UnitedHealth Group and Johnson & Johnson report Tuesday, Abbott Labs on Wednesday, and Honeywell, Schlumberger and Danaher on Thursday.

Bullish Start to Earnings: Cramer's 'Mad Money' Recap (Friday 4/12/19)

Bullish Start to Earnings: Cramer's 'Mad Money' Recap (Friday 4/12/19)

Jim Cramer says this positive start will be hard to sustain this earnings season. He's got your game plan for next week.

Weekly Roundup

Stocks grind higher as earnings season kicks indexes into gear.

Jim Cramer: Do These 5 Powerful Analyst Downgrades Make the Grade?

Jim Cramer: Do These 5 Powerful Analyst Downgrades Make the Grade?

Monday was a demonstration of pretty much everything analysts can throw at stocks to get you out while the getting is still good.

Hope May Be Misplaced in General Electric's Turnaround as Recession Risk Looms

Hope May Be Misplaced in General Electric's Turnaround as Recession Risk Looms

Time could run out before Larry Culp can complete his turnaround plan at GE.

General Electric Slumps After JPMorgan's Stephen Tusa Cuts Rating, Price Target

General Electric Slumps After JPMorgan's Stephen Tusa Cuts Rating, Price Target

General Electric shares fell the most in a month Monday after one of Wall Street's most influential analysts lowered his rating for the struggling industrial giant and cut the group's price target.

GE Stock Jolted as Key Analyst Cuts Target Price

GE Stock Jolted as Key Analyst Cuts Target Price

GE stock hasn't solved its free cash flow conundrum, and might not for some time, says a key analyst.

Weekly Roundup

Markets pushed higher as we gear up for first-quarter results starting next week.

Weekly Roundup

Markets move higher as investors shrug off slowing growth to focus on U.S.-China Trade Deal hopes.

Markets Lower Wednesday but We Have Been Raising Cash

We have long cautioned on our member-only conference calls about the flush of IPOs coming to market and its impact to stocks.

Weekly Roundup

Stocks finish week sharply lower on worries over global economic growth slowing after earlier surging on Fed's more accommodating stance.

Markets Open Lower Friday, a Check on CVS Health After Last Night's Interview

We are encouraged with CVS Health's plans to fix what has hurt the company and we reiterate that the stock is still inexpensive.

Danaher Schedules First Quarter 2019 Earnings Conference Call

Danaher Schedules First Quarter 2019 Earnings Conference Call

WASHINGTON, March 19, 2019 /PRNewswire/ --Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the first quarter 2019 on Thursday, April 18, 2019 beginning at 8:00 a.

Taking Additional Gains in Danaher

We will lighten up on this position and use our big gains as a source of capital.

Weekly Roundup

Strong earnings boost shares in a rebound week for stocks.

The Perils of Stock Investing: Cramer's 'Mad Money' Recap (Thursday 3/14/19)

The Perils of Stock Investing: Cramer's 'Mad Money' Recap (Thursday 3/14/19)

On the 14th anniversary for 'Mad Money', Jim Cramer talks about how to balance owning index funds and individual stocks.

GE's Wake Up Call

GE's Wake Up Call

Victory at General Electric will likely have to wait.

TheStreet Quant Rating: A+ (Buy)